David P. Warren has 5 audiobooks on Listento.it, narrated by 2 narrators. The most-rated is A Secret to Die For.

Attorney Scott Winslow and CIA agent-turned-investigator Lee Henry are back with another extraordinary case. Scott must prove that a powerful company CEO raped his subordinate, Sarah Willis, on a business trip. Investigator Lee Henry employs his CIA background, and unorthodox practices, to chase evidence and help Scott prosecute the case. While Scott goes all in on the case, Lee reaches behind opaque curtains to search for clues. But can they piece it all together and win the case? Personal Violation is a fictional account of a real world horror. It portrays the substantial injury caused by rape, and what a woman who makes a stand confronts in seeking justice. The story also provides insights into the legal system as the case makes its way to trial, and twists and turns along the way.
©2019 David P. Warren (P)2019 David P. Warren

When experienced employment attorney Scott Winslow takes on a whistle-blower case for fired energy company executive Kevin Walters, actions are set in motion that will change lives forever. Scott pursues a lawsuit alleging that his client was fired for complaining about unsafe conditions in the company's mines that endangered workers. Along the way, Scott discovers that government records were altered in the wake of an explosion that killed one mine worker and injured three others. As they search, Scott and his team discover blackmail, sanitized records, and a corporate cover-up. And something else - there is someone out there who wants the case dismissed at all costs, enough to threaten them and then to come after Kevin Walters, as well as Scott and his family. They all find themselves targets of that someone with his own agenda as they chase the evidence they need to prove the case at trial.
©2017 David P. Warren (P)2018 David P. Warren

Successful attorney and newly elected Congressman Brian Madsen has a beautiful wife and a great career. He has done everything right. Until now. At his inaugural, a congratulatory kiss from a campaign worker leads to passionate lovemaking. He waits for guilt to find him, but instead becomes embroiled in an affair, and his fate is sealed. A single decision in a moment of passion changes Brian's life. Soon, the path he has taken leads to murder, blackmail, and mortal danger to anyone Brian turns to for assistance.
©2003 David P. Warren (P)2018 David P. Warren

Altering Destiny is the story of Lynn Kelly, a young woman who, upon the discovery of almost a million dollars, finds her life-altering dreams soon becoming nightmares as she is relentlessly pursued for the money and for something else - something she does not know she has. When she discovers what she has inadvertently stumbled on, she soon learns that there is no way back and nowhere to turn. Neither the unidentified men chasing her nor the police can allow her to publicly reveal what she has discovered. As Lynn attempts to run, the people around her are used as pawns in a game with no limits. Lynn's pursuers will stop at nothing to get the money and the object.
©2017 David P. Warren (P)2018 David P. Warren

When two executives in the pharmaceutical industry step forward to complain the drug test results being published are not accurate, they don’t expect to be fired; and they don’t expect anyone to be stalked, beaten, or killed. They have no idea what they will be up against for revealing a secret that will cost their employer billions of dollars. Aligor Pharmaceuticals has a new drug that they say will revolutionize cancer treatment, with the possibility of rescuing many in the final stages of the disease. Delexane is only weeks from FDA approval as the phase three trials conclude. The product is already generating millions of dollars with news of its arrival causing the stock price to soar. In a couple of months, the product will be released, and millions battling cancer are expected to benefit. The problem is, the 65 percent success rate that resulted in the first two phases of the drug test has fallen to only 12 percent in phase three, the biggest test group of the product trials, but Aligor continues to publicize a 65 percent success rate. Witnessing the failures of phase three, Aligor executives Martin Cardenas and Justin Palmer repeatedly approach Aligor’s top management about the discrepancy between the results the company continues to publish and the results actually documented. To the CEO, their continued silence becomes a question of loyalty. They are both abruptly terminated - and the fight begins. This is a timely story of a drug that is desperately needed in society. But Delexane is about to be rushed to the market prematurely, with its true performance and side effects hidden. And when a drug company doesn’t disclose the real data about a potential new drug to regulators or the public, there are millions of potential victims. Attorney Scott Winslow accepts representation of fired executives Cardenas and Palmer and goes to war with the pharma giant. Investigator Lee Henry goes to great lengths to access critical evidence.
©2020 David P. Warren (P)2020 David P. Warren